May. 1 at 2:32 PM
Indivior (
$INDV) releases pivotal pregnancy safety data for SUBLOCADE - no increased risks vs general population in 322 cases. While this expands addressable market, Q1 revenue still down 6.3% YoY and negative equity (-
$286M) lingers. Safety profile strengthens but financials remain shaky.
https://www.prnewswire.com/news-releases/new-study-highlights-monthly-sublocade-as-a-potential-treatment-option-for-opioid-use-disorder-during-and-after-pregnancy-302444173.html